Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add filters








Language
Year range
1.
Journal of Experimental Hematology ; (6): 360-364, 2019.
Article in Chinese | WPRIM | ID: wpr-774309

ABSTRACT

OBJECTIVE@#To investigate the safety and efficacy of autologous peripheral blood hematopoietic stem cell transplantation (auto-PBHSCT) using modified BU/CY conditioning regimen for young AML patients of low and middle risk in the first complete remission (CR1).@*METHODS@#Ten young AML patients of low and middle risk who did not want to accept allogeneic hematopoietic stem cell transplantation(allo-HSCT)and underwent auto-PBHSCT in CR1 during May 2013 to December 2016 were retrospectively analyzed. From 3 months after auto-PBHSCT, the maintenance therapy with interleukin-2 (IL-2) or IL-2 combined with histamine dihydrochloride was performed for these patients in the next 18 months. The side effects of the conditioning regimen, hematopoietic recovery time, transplant-related mortality (TRM) within 100 days and 1 year after auto-PBHSCT, relapse rate, leukemia-free survival (LFS) rate at 2 years and 3 years, overall survival (OS) were evaluated at 3 years and 4 years.@*RESULTS@#Gastrointestinal side effects were the major non-hematologic toxicity reaction, among which, 7 cases relatively mild and 3 cases displayed moderate, just one case suffered from severe reaction. In 4 cases, the mild liver damage occurred, but no hemorrhagic cystitis occurred. All the patients experienced different kinds of infection, including 5 cases of bloodstream infection, 2 cases of gastrointestinal infection, 3 cases of crissum infection and 2 cases of oral infection. The myeloablative effect occurred in all ten patients. The median times for absolute neutrophil count (ANC)0.5×10/L at 10 to 19 days, median was 13 days after auto-PBHSCT. The patients achieved platelet count >20×10/L at 10 to 72 days; median was 32 days after auto-PBHSCT. The TRM within 100 days and 1 year after transplantation was 0. The relapse occurred in 2 cases at 6 and 14 months after auto-PBHSCT raspectively. The median follow-up time was 48.1 months, and the median survival time was 54.7 months after transplantation. The 2-year and 3-year LFS were 100% (10 cases) and 80% (8 cases), respectively. The 3-year and 4-year OS were 80% (8 cases) and 70% (7 cases), respectively.@*CONCLUSION@#Modified BU/CY as conditioning regimen for auto-PBHSCT can achieve the myeloablative effect without raising TRM and obtain good LFS and OS. As for young AML patients without high risk, it is a valuable therapeutic option, especially for those lacking the chance of allo-HSCT.


Subject(s)
Humans , Disease-Free Survival , Hematopoietic Stem Cell Transplantation , Leukemia, Myeloid, Acute , Retrospective Studies , Transplantation Conditioning , Transplantation, Autologous , Treatment Outcome
2.
Chinese Journal of Rehabilitation Theory and Practice ; (12): 704-705, 2006.
Article in Chinese | WPRIM | ID: wpr-974873

ABSTRACT

@#Both dysfunction of pancreatic β cells and β cells apoptosis were important factors contributing to type 2 diabetes. Abnormal glucose and lipid metabolism all existed in type 2 diabetes .With the study further progressing, more and more attention were paid to pancreatic β cells apoptosis accelerated by abnormal lipid metabolism. The literature about β cells injury by lipotoxicity, apoptosis induced factors accompanied by free fatty acids, and relevant mechanism was reviewed in this article.

3.
Chinese Journal of Preventive Medicine ; (12): 355-358, 2006.
Article in Chinese | WPRIM | ID: wpr-290258

ABSTRACT

<p><b>OBJECTIVE</b>To understand the immune level of the purified protein derivative (PPD) and the present conditions of the tuberculosis among the collegians.</p><p><b>METHODS</b>Standardized tuberculin testing with PPD 5 IU, social-demographic and epidemiological feature of tuberculosis were conducted in 105,239 freshmen from 33 universities in Beijing.</p><p><b>RESULTS</b>The scar rates of freshmen were 72.21%. The rates coming from cities were higher than those from countries. The scar rates were near equal for freshmen in different ages. However the rates were different evidently with the region where the students come from. The scar rates of freshmen from cities were 75.84%. The scar rates of the freshmen from countries were 62.78%. Tuberculosis infection rate of the freshmen was 51.99% and the strong positive rate was 14.63%. Tuberculosis positive rate of city students was obviously higher than that of rural ones. Tuberculosis positive rate of city students was 55.17% and the strong positive rate was 15.37%. Tuberculosis positive rate of rural students was 44.69% and the strong positive rate was 12.70%. There appeared great difference between them. Moreover, Tuberculosis infection rate was varied with age and region. The tuberculosis positive rate of students from north-east areas was the highest (72.10%, 7,746/10,744), and those come from the middle-north areas were the lowest (41.50%, 6,560/15,808). The tuberculosis positive rate (62.49%, 47,489/75,992) of the freshmen with the scar was higher than that of those without the scar (24.72%, 7,230/29,247). The tuberculosis positive rate of the freshmen having a touch with the tuberculosis cases (60.75%) was higher than those having not (51.96%).</p><p><b>CONCLUSION</b>As students in universities are susceptible population of tuberculosis, it should be emphasized to find out tuberculosis in university and to treat them early for the purpose of preventing the episode and explosion of the disease.</p>


Subject(s)
Adolescent , Female , Humans , Male , Young Adult , China , Epidemiology , Rural Population , Students , Tuberculin Test , Tuberculosis, Pulmonary , Epidemiology , Universities , Urban Population
4.
Chinese Journal of Plastic Surgery ; (6): 211-213, 2003.
Article in Chinese | WPRIM | ID: wpr-256444

ABSTRACT

<p><b>OBJECTIVE</b>To investigate flap survival after transfection using gene encoding vascular endothelial growth factor (VEGF).</p><p><b>METHODS</b>In 30 Sprague-Dawley rats, the anterior abdominal skin flap supplied by the epigastric vessels was created. The animals were divided into three groups, with ten of each. The first group was treated with a mixture of liposomes and the cDNA encoding the 165-amino acid isoform of VEGF; the second group was treated with control blank plasmid DNA and liposome transfection medium; the third group was treated with physiological saline. Four days after injection, the epigastric artery and vein were ligated and the blood flow in the flap was evaluated by intraperitoneal injection of fluorescence solution. Seven days later, the survival area of the flap was measured by planimetry. After the animals were killed, specimens were harvested from the anterior abdomen skin flap for immunohistological evidence of VEGF expression and for hematoxylin and eosin staining of microvascular growth.</p><p><b>RESULTS</b>30 minutes after pedicle ligation the average fluorescence staining planimetry of the three groups (PCD-VEGF165, PCD and physiological saline) was 60.64%, 30.15% and 29.89% respectively. Tissue survival planimetry of the three groups was 92.3%, 30.5%, 31.8%. There was significant difference between the first group and the latter two (P < 0.05). Immunohistochemical staining documented increased deposition of VEGF cDNA in the first group compared to the control groups (P < 0.05). Normal staining documented that the average vessel number of the three groups was 101.72, 91.35 and 89.85 (P < 0.05), the average vessel lumen diameter was 26 microns, 31.09 microns and 32.51 microns(P < 0.05).</p><p><b>CONCLUSION</b>Through administration, PCD-VEGF165 can transfect the anterior abdominal skin flap and enhance its survival. There was express of VEGF protein in the treated flap.</p>


Subject(s)
Animals , Rats , Biomarkers , Metabolism , DNA, Complementary , Epigastric Arteries , Genetic Therapy , Graft Survival , Physiology , Liposomes , Plasmids , Rats, Sprague-Dawley , Surgical Flaps , Physiology , Time Factors , Transfection , Methods , Vascular Endothelial Growth Factor A , Genetics , Metabolism
SELECTION OF CITATIONS
SEARCH DETAIL